The Clorox Company CLX
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.28% | -5.41% | -3.69% | -5.68% | -9.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.28% | -5.41% | -3.69% | -5.68% | -9.35% |
| Cost of Revenue | 10.73% | -0.51% | -1.53% | -5.08% | -8.89% |
| Gross Profit | 0.67% | -11.35% | -6.32% | -6.43% | -9.92% |
| SG&A Expenses | -0.11% | -4.06% | -10.51% | -8.27% | -8.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 50.00% | 233.33% | 75.00% | -26.32% | -50.00% |
| Total Operating Expenses | 7.08% | -1.49% | -4.42% | -6.26% | -8.98% |
| Operating Income | 1.68% | -24.98% | 0.48% | -2.22% | -11.39% |
| Income Before Tax | -11.61% | -26.62% | 4.77% | 52.40% | 84.62% |
| Income Tax Expenses | -2.93% | -25.20% | -6.84% | 20.67% | 16.48% |
| Earnings from Continuing Operations | -13.82% | -27.06% | 8.60% | 64.53% | 117.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -25.00% | 0.00% | 6.67% | -36.36% | 7.69% |
| Net Income | -14.41% | -27.53% | 8.93% | 65.21% | 121.57% |
| EBIT | 1.68% | -24.98% | 0.48% | -2.22% | -11.39% |
| EBITDA | 4.60% | -19.26% | 2.22% | -0.48% | -8.76% |
| EPS Basic | -13.15% | -26.46% | 10.26% | 66.74% | 123.06% |
| Normalized Basic EPS | -5.19% | -30.46% | 0.68% | -3.11% | -11.34% |
| EPS Diluted | -12.79% | -26.13% | 10.77% | 67.56% | 122.55% |
| Normalized Diluted EPS | -4.98% | -30.25% | 0.96% | -3.02% | -11.43% |
| Average Basic Shares Outstanding | -1.39% | -1.42% | -1.30% | -1.08% | -0.72% |
| Average Diluted Shares Outstanding | -1.60% | -1.73% | -1.60% | -1.18% | -0.62% |
| Dividend Per Share | 0.81% | 1.02% | 1.22% | 2.06% | 2.07% |
| Payout Ratio | 0.17% | 0.38% | -0.08% | -0.39% | -0.54% |